Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted) (2019 - 2026)

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Ginkgo Bioworks Holdings 441.96 Mn 298.10 Mn 16.38 Mn 55.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.46 Mn
Dec 31, 2025 55.46 Mn
Sep 30, 2025 55.63 Mn
Jun 30, 2025 54.86 Mn
Mar 31, 2025 54.24 Mn
Dec 31, 2024 51.89 Mn
Sep 30, 2024 52.25 Mn
Jun 30, 2024 51.38 Mn
Mar 31, 2024 50.13 Mn
Dec 31, 2023 48.61 Mn
Sep 30, 2023 48.77 Mn
Jun 30, 2023 48.34 Mn
Mar 31, 2023 47,916.00
Dec 31, 2022 42.00 Mn
Sep 30, 2022 40.77 Mn
Jun 30, 2022 40.52 Mn
Mar 31, 2022 40,188.00
Dec 31, 2021 34.01 Mn
Sep 30, 2021 33.09 Mn
Jun 30, 2021 32.31 Mn